Inari Medical, Inc.(NARI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NARI Inari Medical, Inc.

休市中 11-01 16:00:00 EDT

48.74

+0.34

+0.70%

盘后47.70

-1.04-2.13%

17:23 EDT

最高48.92	最低48.17	成交量58.94万
今开48.53	昨收48.40	日振幅1.54%
总市值28.53亿	流通市值24.55亿	总股本5,854万
成交额2,865万	换手率1.17%	流通股本5,037万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NARI","market":"US","secType":"STK","nameCN":"Inari Medical, Inc.","latestPrice":48.74,"timestamp":1730491200000,"preClose":48.4,"halted":0,"volume":589361,"hourTrading":{"tag":"盘后","latestPrice":47.7,"preClose":48.74,"latestTime":"17:23 EDT","volume":29500,"amount":1436810.31,"timestamp":1730496192224},"delay":0,"floatShares":50372119,"shares":58544158,"eps":-1.354304,"marketStatus":"休市中","marketStatusCode":7,"change":0.34,"latestTime":"11-01 16:00:00 EDT","open":48.53,"high":48.92,"low":48.173,"amount":28647205.68003,"amplitude":0.015434,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.354304,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730710800000},"adr":0,"listingDate":1590120000000,"adjPreClose":48.4,"preHourTrading":{"tag":"盘前","latestPrice":48.4003,"preClose":48.4,"latestTime":"09:11 EDT","volume":11419,"amount":552683.0257,"timestamp":1730466692578},"postHourTrading":{"tag":"盘后","latestPrice":47.7,"preClose":48.74,"latestTime":"17:23 EDT","volume":29500,"amount":1436810.31,"timestamp":1730496192224},"volumeRatio":0.356489962847399,"impliedVol":0.5587,"impliedVolPercentile":0.4603},"requestUrl":"/m/hq/s/NARI","defaultTab":"news","newsList":[{"id":"2480839882","title":"Inari Medical, Inc.2024财年第三财季实现净利润-18.37百万美元，同比减少681.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480839882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480839882?lang=zh_cn&edition=full","pubTime":"2024-11-02 00:01","pubTimestamp":1730476868,"startTime":"0","endTime":"0","summary":"11月2日，Inari Medical, Inc.公布财报，公告显示公司2024财年第三财季净利润为-18.37百万美元，同比减少681.33%；其中营业收入为1.53亿美元，同比增加21.43%，每股基本收益为-0.31美元。机构评级：截至2024年11月2日，当前有14家机构对Inari Medical, Inc.目标价做出预测，其中目标均价为64.57美元，其中最低目标价为48.00美元，最高目标价为86.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102000120ab938042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102000120ab938042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NARI"],"gpt_icon":0},{"id":"2479033737","title":"Inari Medical, Inc.盘中异动 早盘股价大涨5.65%报49.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033737?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:50","pubTimestamp":1730382607,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时50分，Inari Medical, Inc.股票出现波动，股价大幅拉升5.65%。截至发稿，该股报49.76美元/股，成交量3.7344万股，换手率0.06%，振幅5.39%。Inari Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.29%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121500798e3fb94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121500798e3fb94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0390134368.USD","NARI","BK4082"],"gpt_icon":0},{"id":"1153516746","title":"异动解读 | Inari Medical业绩增长强劲引爆股价 未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=1153516746","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153516746?lang=zh_cn&edition=full","pubTime":"2024-10-30 09:18","pubTimestamp":1730251117,"startTime":"0","endTime":"0","summary":"2024年10月29日,医疗器械公司Inari Medical, Inc. 在盘中出现大涨近20%的强劲行情,股价一度触及49.58美元/股的新高。市场关注的焦点集中在该公司当天发布的2024年第三季度财报数据上。财报显示,Inari Medical第三季度营收达到1.5339亿美元,同比增长21.4%,超出分析师预期。随后在业绩电话会上,Inari Medical同时上调了2024年全年营收预期的下限,将全年营收预期上调至6.015亿至6.045亿美元,预计同比增长22%至22.5%。这一系列利好因素令投资者对Inari Medical的长期成长前景更加乐观。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NARI"],"gpt_icon":0},{"id":"2479299672","title":"Inari Medical, Inc. ：公司将全年收入指导上调至6.015亿至6.045亿美元，预期增长22%至22.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479299672","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479299672?lang=zh_cn&edition=full","pubTime":"2024-10-30 09:10","pubTimestamp":1730250600,"startTime":"0","endTime":"0","summary":"Inari Medical, Inc. 2024年第三季度业绩电话会：报告了创纪录的1.534亿美元收入，同比增长21%。全球VTE收入为1.453亿美元，增长19.7%，新兴疗法业务收入超过800万美元，增长64%，国际业务收入1150万美元，增长76.4%。毛利率为87.1%，营业费用为1.471亿美元，研发费用为2940万美元。公司预计2024年第四季度GAAP营业收入将大致达到盈亏平衡，并重申在2025年上半年实现持续运营盈利的预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/us/2024-10-30/doc-incuhwif7012807.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2024-10-30/doc-incuhwif7012807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0390134368.USD","NARI","BK4082"],"gpt_icon":0},{"id":"1190045226","title":"异动解读 | Inari Medical利好财报数据超预期 股价大涨12%引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1190045226","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190045226?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:34","pubTimestamp":1730208892,"startTime":"0","endTime":"0","summary":"作为一家新兴的医疗器械公司,Inari Medical, Inc.近期股价大涨12.08%,引发市场广泛关注。推动这一涨势的主因是公司2024年第三季度业绩数据优于预期。Inari Medical第三季度财报显示,公司调整后每股亏损仅为9美分,远好于分析师预期的11美分亏损水平。虽然Inari Medical目前仍处于亏损状态,但近年来其业绩一直保持着高速增长态势。多家机构上调了对该公司的目标价,认为其长期成长空间广阔。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NARI"],"gpt_icon":0},{"id":"2479857312","title":"Adagio Medical Holdings, Inc盘中异动 股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479857312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479857312?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208744,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Adagio Medical Holdings, Inc股票出现波动，股价大幅拉升6.16%。Adagio Medical Holdings, Inc股票所在的医疗器械行业中，整体跌幅为0.31%。其相关个股中，Inari Medical, Inc.、Icecure Medical Ltd.、Nanovibronix, Inc.涨幅较大，Autonomix Medical, Inc.、Transmedics Group, Inc.、Nexalin Technology, Inc.较为活跃，换手率分别为7.00%、3.61%、3.51%，振幅较大的相关个股有Sera Prognostics, Inc.、Inari Medical, Inc.、Transmedics Group, Inc.，振幅分别为6.71%、5.63%、5.01%。Adagio Medical Holdings, Inc公司简介：Adagio Medical Holdings Inc 是治疗心律失常的导管消融技术的创新者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921322495bd8206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921322495bd8206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADGM","NARI","BK4082","LU0390134368.USD"],"gpt_icon":0},{"id":"2479289199","title":"Inari Medical, Inc.盘中异动 早盘股价大涨16.48%报49.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479289199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479289199?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208739,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Inari Medical, Inc.股票出现异动，股价急速拉升16.48%。Inari Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.31%。其相关个股中，Inari Medical, Inc.、Icecure Medical Ltd.、Nanovibronix, Inc.涨幅较大，Autonomix Medical, Inc.、Transmedics Group, Inc.、Nexalin Technology, Inc.较为活跃，换手率分别为7.00%、3.57%、3.51%，振幅较大的相关个股有Sera Prognostics, Inc.、Inari Medical, Inc.、Transmedics Group, Inc.，振幅分别为6.71%、5.63%、5.01%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921322095bd8201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921322095bd8201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NARI","LU0390134368.USD","BK4082"],"gpt_icon":0},{"id":"2479406590","title":"BUZZ--美国股票走势-麦当劳、斑马技术公司、辉瑞公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479406590","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479406590?lang=zh_cn&edition=full","pubTime":"2024-10-29 20:05","pubTimestamp":1730203554,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月29日 - 周二，美国股指期货变化不大，因为投资者准备迎接众多企业的业绩，尤其是Alphabet  的业绩，以衡量科技板块的强弱。标普500指数小型股  下跌0.10%，报5855.5点；纳斯达克100指数小型股  上涨0.01%，报20499.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca5fccc33a5f91842e4d17dcec823d1b","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VZ","LU1244550221.USD","TMDX","LU0708994859.HKD","LU1718418525.SGD","IE0005OL40V9.USD","IE00B19Z9505.USD","KDP","LU0320765489.SGD","LU2133065610.SGD","LU1303367103.USD","IE00BFSS7M15.SGD","T","TMUS","IE00BLSP4452.SGD","FLG","LU1430594728.SGD","ZBRA","PYPL","IE00B7KXQ091.USD","IE000W1ABFV2.USD","LU0128525929.USD","LU0149725797.USD","RCL","NARI","MCD","SGXZ57979304.SGD","LU2247934214.USD","VFC","LU0158827948.USD","DTE","HK0000306685.HKD","LU1894683264.USD","BK4106","LU2098885051.SGD","IE0004445239.USD","LU1280957306.USD","LU1914381329.SGD","BK4177","BK4561","LU1244550494.USD","IE00B3SWFQ91.USD","LU0029864427.USD","IE00BJTD4N35.SGD","IE00BN29S564.USD","IE00BZ1G4Q59.USD","BK4507","PFE","LU1699723380.USD"],"gpt_icon":1},{"id":"2479470016","title":"BUZZ-稻盛和夫小幅上调年度收入预期，业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479470016","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479470016?lang=zh_cn&edition=full","pubTime":"2024-10-29 19:21","pubTimestamp":1730200902,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月29日 - ** 医疗设备制造商英纳利医疗  股价盘前上涨约7%至45.56美元** 周一晚些时候，英纳利（(link)）将其2024年全年营收预期的下限从之前的5.945亿美元至6.045亿美元上调至6.015亿美元 至6.045亿美元。** 公司第三季度收入为 1.5339 亿美元 ，高于分析师平均预期的 1.5067 亿美元 - LSEG** 公司继续预计在 2025 年上半年实现持续运营盈利      ** 业绩公布后，至少有两位分析师上调了该公司的预测值** 截至上次收盘，股价累计下跌 34.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NARI","LU0390134368.USD"],"gpt_icon":0},{"id":"1195161762","title":"异动解读 | 利好财报数据超预期 Inari Medical盘前股价大涨8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1195161762","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195161762?lang=zh_cn&edition=full","pubTime":"2024-10-29 18:34","pubTimestamp":1730198065,"startTime":"0","endTime":"0","summary":"医疗器械公司Inari Medical, Inc. (NARI)2024年第三季度财报数据超出分析师预期,推动其股价在盘前大涨8.06%。\n具体来看,Inari Medical第三季度调整后每股亏损为9美分,优于预期的11美分亏损,营收同比增长21.4%至1.5339亿美元,也高于市场预期水平。\n虽然该公司仍处于亏损状态,但良好的业绩数据和持续高速增长使其获得市场认可。目前分析师给予Inari Medical一致的\"买入\"评级,看好其在医疗器械领域的长期成长空间。未来几个季度业绩持续超预期可期,有望进一步推动股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NARI"],"gpt_icon":0},{"id":"1164234197","title":"异动解读 | Inari Medical Q3财报超预期,股价夜盘大涨12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164234197","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164234197?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:54","pubTimestamp":1730195668,"startTime":"0","endTime":"0","summary":"Inari Medical, Inc. 周六晚间股价大涨12.03%,引发了市场广泛关注。主导这一涨势的主因来自于公司2024年第三季度业绩数据超出预期。该公司Q3财报显示,调整后每股亏损为9美分,优于华尔街分析师预期的11美分亏损。作为一家新兴的医疗器械公司,Inari Medical过去几个季度持续保持高速增长,受到分析师普遍看好。即便本季度仍处于亏损状态,但良好的业绩预期和未来发展潜力使其股价获得提振。目前,分析师给予Inari Medical一致的\"买入\"评级,认为公司长期成长空间广阔。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NARI"],"gpt_icon":0},{"id":"2479444458","title":"美国研究综述-Coinbase Global、Meta、联合太平洋公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479444458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479444458?lang=zh_cn&edition=full","pubTime":"2024-10-29 14:41","pubTimestamp":1730184072,"startTime":"0","endTime":"0","summary":"    路透10月29日 - 华尔街证券分析师周二调整了对 Coinbase Global、Meta 和联合太平洋等几家美国上市公司的评级和目标价。要点             * Coinbase Global Inc   ：摩根大通将目标价从181美元上调至196美元             * Meta   ：Wedbush将目标价从600美元上调至640美元             * Union Pacific Corp   ：大和资本市场将目标价从250美元下调至240美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4624e84750d72ade2ebcb09583409b58","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","BK4585","LU0266013472.USD","UNP","HON","OLN","CX","IE0005OL40V9.USD","TMDX","VFC","MHK","CCB","COIN","BK4507","NCLH","LU0198837287.USD","IE0034235303.USD","LU0390134368.USD","BK4121","BK4588","EL","NARI","NTRA","IE00B1BXHZ80.USD","BK4202","IE00BK4W5M84.HKD","AMKR","IE00B7KXQ091.USD","LU2065171402.SGD","BK4142","META","RCL","BK4090","FFIV","WST","BK4086","MGA","CSTL","LU2756315664.SGD","EXAS","DAN","SBAC","LU2065171311.SGD","TREX","SARO","LU2552382215.SGD","LU0068578508.USD","IE00BQXX3D17.EUR","LU0061475181.USD","LU1861219969.SGD"],"gpt_icon":1},{"id":"1183855535","title":"异动解读 | Inari Medical, Inc.财报超预期,股价夜盘大涨12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183855535","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183855535?lang=zh_cn&edition=full","pubTime":"2024-10-29 10:50","pubTimestamp":1730170228,"startTime":"0","endTime":"0","summary":"医疗器械公司 Inari Medical, Inc. (NARI) 股价在周六晚间大涨12.03%,主要受到该公司2024年第三季度财报数据超预期利好消息的推动。\n\n财报显示,Inari Medical第三季度调整后每股亏损9美分,优于分析师预期的11美分亏损。同时,公司营收同比增长21.4%至1.5339亿美元,也超出了市场预期。\n\n虽然Inari Medical仍处于亏损状态,但本季度业绩好于预期。公司在医疗器械领域的营收增长迅速,未来发展前景获得市场认可。目前分析师一致给予该公司\"买入\"评级,看好其长期成长空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NARI"],"gpt_icon":0},{"id":"2479413558","title":"稻盛和夫医疗公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479413558","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479413558?lang=zh_cn&edition=full","pubTime":"2024-10-29 10:47","pubTimestamp":1730170070,"startTime":"0","endTime":"0","summary":"   * Inari Medical Inc   报告了截至9月30日的季度调整后每股亏损9美分，低于去年同期的每股收益5美分。华尔街预期为每股-18美分至-2美分。* 营收同比增长 21.4%，达到 1.5339 亿美元；分析师预期为 1.5067 亿美元。* Inari Medical Inc公布的本季度每股收益为亏损31美分。* Inari Medical Inc本季度股价上涨了6.0%，今年迄今为止亏损了32.7%。华尔街对 Inari Medical Inc 的 12 个月目标价中位数为 65.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"稻盛和夫医疗公司公布截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI"],"gpt_icon":0},{"id":"2475666897","title":"Inari Medical, Inc.盘中异动 股价大涨5.02%报44.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475666897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475666897?lang=zh_cn&edition=full","pubTime":"2024-10-16 03:08","pubTimestamp":1729019338,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日03时08分，Inari Medical, Inc.股票出现波动，股价大幅上涨5.02%。截至发稿，该股报44.32美元/股，成交量50.639万股，换手率0.87%，振幅5.39%。Inari Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.12%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016030858971a072e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016030858971a072e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NARI","LU0390134368.USD"],"gpt_icon":0},{"id":"2475639619","title":"Inari Medical, Inc.盘中异动 快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475639619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475639619?lang=zh_cn&edition=full","pubTime":"2024-10-14 23:10","pubTimestamp":1728918639,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日23时10分，Inari Medical, Inc.股票出现波动，股价快速上涨5.00%。Inari Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.40%。其相关个股中，Dih Holdings Us Inc C/Wts 20/04/2028 、Heartsciences Inc C/Wts 、Nexalin Technology, Inc.涨幅较大，Nanovibronix, Inc.、Bluejay Diagnostics, Inc.、Tenon Medical, Inc.较为活跃，换手率分别为106.76%、37.09%、21.62%，振幅较大的相关个股有Nanovibronix, Inc.、Trinity Biotech Plc、Envoy Medical, Inc.，振幅分别为37.57%、25.00%、20.22%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014231040a1e09110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014231040a1e09110&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0390134368.USD","NARI","BK4082"],"gpt_icon":0},{"id":"2472060955","title":"Inari Medical, Inc.盘中异动 临近收盘股价大涨5.01%报42.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472060955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472060955?lang=zh_cn&edition=full","pubTime":"2024-10-03 03:56","pubTimestamp":1727899007,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日03时56分，Inari Medical, Inc.股票出现波动，股价大幅上涨5.01%。截至发稿，该股报42.67美元/股，成交量72.1569万股，换手率1.24%，振幅5.17%。Inari Medical, Inc.股票所在的医疗器械行业中，整体跌幅为0.28%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003035648a1de0b6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003035648a1de0b6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0390134368.USD","BK4082","NARI"],"gpt_icon":0},{"id":"2461222885","title":"美国 FDA 将伊纳里导管设备召回列为 \"最严重 \"事件","url":"https://stock-news.laohu8.com/highlight/detail?id=2461222885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461222885?lang=zh_cn&edition=full","pubTime":"2024-08-24 06:31","pubTimestamp":1724452286,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月23日 - 美国食品和药物管理局周五将Inari Medical公司的   ClotTriever导管列为 \"最严重 \"召回产品，该导管有助于捕捉和清除大血管中的大块血凝块。 美国食品和药物管理局说，受影响的产品包括标签日期在2024年8月1日之前的所有器械和批号，使用这些产品可能会对健康造成严重不良后果，包括器械夹伤、血管损伤和/或肺动脉阻塞和死亡。 根据卫生监管机构的声明 (link)，目前已有四起受伤报告和六起死亡报告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI","BK4082","LU0390134368.USD"],"gpt_icon":0},{"id":"2459718114","title":"Inari Medical, Inc.盘中异动 快速上涨5.01%报49.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459718114","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459718114?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:15","pubTimestamp":1723734913,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时15分，Inari Medical, Inc.股票出现波动，股价快速拉升5.01%。Inari Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.78%。其相关个股中，精确射线、Nevro Corp.、Standard Biotools Inc.涨幅较大，精确射线、Nuwellis, Inc.、Aethlon Medical, Inc.较为活跃，换手率分别为10.13%、5.85%、3.48%，振幅较大的相关个股有精确射线、Spectral Ai Inc C/Wts 、Nevro Corp.，振幅分别为26.57%、19.41%、16.62%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523151397198d7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523151397198d7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NARI","LU0390134368.USD","BK4082"],"gpt_icon":0},{"id":"2459248122","title":"Inari Medical, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459248122","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459248122?lang=zh_cn&edition=full","pubTime":"2024-08-15 02:55","pubTimestamp":1723661723,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日02时55分，Inari Medical, Inc.股票出现波动，股价急速跳水5.07%。Inari Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.65%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Spectral Ai Inc C/Wts 、Elutia, Inc.涨幅较大，Nuwellis, Inc.、Aethlon Medical, Inc.、Icecure Medical Ltd.较为活跃，换手率分别为33.19%、20.75%、12.12%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Holdco Nuvo Group D G Ltd C/Wts 01/05/2029 、Asensus Surgical, Inc.，振幅分别为140.98%、55.84%、47.39%。Inari Medical, Inc.公司简介：Inari Medical Inc 是一家医疗器械公司，专注于开发治疗慢性静脉疾病患者的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081502552397198bf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081502552397198bf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","NARI","LU0390134368.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.inarimedical.com","stockEarnings":[{"period":"1week","weight":0.1153},{"period":"1month","weight":0.1383},{"period":"3month","weight":0.0302},{"period":"6month","weight":0.1596},{"period":"1year","weight":-0.0441},{"period":"ytd","weight":-0.2492}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inari Medical, Inc. 于2011年7月在特拉华州成立，总部位于加利福尼亚州尔湾。 该公司是一家商业阶段的医疗设备公司，致力于开发产品以治疗和改变患有静脉疾病的患者的生活。 他们开发，制造，销售和销售用于静脉疾病的介入治疗的设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.081523},{"month":2,"riseRate":0.5,"avgChangeRate":0.022055},{"month":3,"riseRate":1,"avgChangeRate":0.047729},{"month":4,"riseRate":0.5,"avgChangeRate":-0.046873},{"month":5,"riseRate":0.25,"avgChangeRate":-0.043859},{"month":6,"riseRate":0.6,"avgChangeRate":0.026515},{"month":7,"riseRate":0.4,"avgChangeRate":0.042564},{"month":8,"riseRate":0.4,"avgChangeRate":0.064666},{"month":9,"riseRate":0.2,"avgChangeRate":-0.032558},{"month":10,"riseRate":0.6,"avgChangeRate":0.047252},{"month":11,"riseRate":0.4,"avgChangeRate":-0.019625},{"month":12,"riseRate":0.75,"avgChangeRate":0.08025}],"exchange":"NASDAQ","name":"Inari Medical, Inc.","nameEN":"Inari Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inari Medical, Inc.(NARI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inari Medical, Inc.(NARI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inari Medical, Inc.,NARI,Inari Medical, Inc.股票,Inari Medical, Inc.股票老虎,Inari Medical, Inc.股票老虎国际,Inari Medical, Inc.行情,Inari Medical, Inc.股票行情,Inari Medical, Inc.股价,Inari Medical, Inc.股市,Inari Medical, Inc.股票价格,Inari Medical, Inc.股票交易,Inari Medical, Inc.股票购买,Inari Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inari Medical, Inc.(NARI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inari Medical, Inc.(NARI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}